These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 2354441)

  • 1. Prolonged survival of tumor-bearing rats with repetitive low-dose recombinant tumor necrosis factor.
    Sheppard BC; Venzon D; Fraker DL; Langstein HN; Jensen JC; Norton JA
    Cancer Res; 1990 Jul; 50(13):3928-33. PubMed ID: 2354441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The roles of gamma-interferon and tumor necrosis factor alpha in an experimental rat model of cancer cachexia.
    Langstein HN; Doherty GM; Fraker DL; Buresh CM; Norton JA
    Cancer Res; 1991 May; 51(9):2302-6. PubMed ID: 1901758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of insulin on doxorubicin-induced rat host toxicity and tumor regression.
    Peacock JL; Gorschboth CM; Norton JA
    Cancer Res; 1987 Aug; 47(16):4318-22. PubMed ID: 3300963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin reversal of cancer cachexia in rats.
    Moley JF; Morrison SD; Norton JA
    Cancer Res; 1985 Oct; 45(10):4925-31. PubMed ID: 3896470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Body composition changes in rats with experimental cancer cachexia: improvement with exogenous insulin.
    Moley JF; Morrison SD; Gorschboth CM; Norton JA
    Cancer Res; 1988 May; 48(10):2784-7. PubMed ID: 3282649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cachectin/tumor necrosis factor: a possible mediator of cancer anorexia in the rat.
    Stovroff MC; Fraker DL; Swedenborg JA; Norton JA
    Cancer Res; 1988 Aug; 48(16):4567-72. PubMed ID: 3165053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cachectic effects of recombinant human tumor necrosis factor in rats.
    Darling G; Fraker DL; Jensen JC; Gorschboth CM; Norton JA
    Cancer Res; 1990 Jul; 50(13):4008-13. PubMed ID: 2354450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parabiotic transfer of cancer anorexia/cachexia in male rats.
    Norton JA; Moley JF; Green MV; Carson RE; Morrison SD
    Cancer Res; 1985 Nov; 45(11 Pt 1):5547-52. PubMed ID: 3863707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of indomethacin, cytokines, and cyclosporin A on tumor growth and the subsequent development of cancer cachexia.
    Gelin J; Andersson C; Lundholm K
    Cancer Res; 1991 Feb; 51(3):880-5. PubMed ID: 1988128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of antitumour activity of human recombinant tumour necrosis factor-alpha, alone or in combination with melphalan in a nude mouse human melanoma xenograft system.
    Furrer M; Altermatt HJ; Ris HB; Althaus U; Rüegg C; Liénard D; Lejeune FJ
    Melanoma Res; 1997 Aug; 7 Suppl 2():S43-9. PubMed ID: 9578416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of omega-3 fatty acid supplementation on tumor-bearing rats.
    Ramos EJ; Middleton FA; Laviano A; Sato T; Romanova I; Das UN; Chen C; Qi Y; Meguid MM
    J Am Coll Surg; 2004 Nov; 199(5):716-23. PubMed ID: 15501111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of insulin on survival of cachectic tumor-bearing rats.
    Peacock JL; Norton JA
    JPEN J Parenter Enteral Nutr; 1988; 12(3):260-4. PubMed ID: 3392822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-tumor activity of recombinant tumor necrosis factor on mouse fibrosarcoma in vivo and in vitro.
    Tomazic VJ; Farha M; Loftus A; Elias EG
    J Immunol; 1988 Jun; 140(11):4056-61. PubMed ID: 3372997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of tumor necrosis factor alpha on skeletal muscle and Walker 256 carcinosarcoma protein metabolism studied in vivo.
    Tayek JA; Brasel JA
    Cancer Res; 1990 May; 50(9):2765-8. PubMed ID: 2328503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of altered taste preferences in tumor-bearing rats.
    Smith BK; Barker K; Schork MA; Kluger MJ
    Appetite; 1994 Dec; 23(3):219-30. PubMed ID: 7726541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NTP Toxicology and Carcinogenesis Studies of Theophylline (CAS No. 58-55-9) in F344/N Rats and B6C3F1 Mice (Feed and Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1998 Aug; 473():1-326. PubMed ID: 12571677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human tumor necrosis factor-alpha: evidence of an indirect mode of antitumor activity.
    Manda T; Shimomura K; Mukumoto S; Kobayashi K; Mizota T; Hirai O; Matsumoto S; Oku T; Nishigaki F; Mori J
    Cancer Res; 1987 Jul; 47(14):3707-11. PubMed ID: 3594435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.